核医学心脏成像的最新进展
该综述聚焦缺血性心脏病、心力衰竭、感染与炎症,指出PET示踪剂如铷-82的普及使心肌灌注可绝对定量;心肌灌注显像PET和SPECT适用于运动或药物负荷,覆盖全心肌并评估缺血负荷,有助于在药物治疗与血运重建间分诊;在心力衰竭、心内膜炎、结节病、心肌炎及转甲状腺素蛋白淀粉样变中具有独特价值。
要点
- PET示踪剂如铷-82的普及使心肌灌注可绝对定量。
- 心肌灌注显像PET和SPECT可评估缺血负荷,帮助分诊血运重建。
- 核素成像在心内膜炎、装置感染、心肌炎及淀粉样变中价值独特。
核心结论
- 放射性核素成像仍是现代心脏病学的重要组成部分,新进展扩展了其作用。
- 心肌灌注显像PET和SPECT的优势包括广泛适用、全心肌覆盖及评估缺血负荷。
研究设计与样本
- 综述,聚焦缺血性心脏病、心力衰竭、感染和炎症。
主要发现
- 铷-82等PET示踪剂更广泛可用,允许以绝对术语量化心肌灌注。
- 心肌灌注显像PET和SPECT的缺点包括部分心脏中心缺乏专业知识和缺乏简单的SPECT量化,可能低估整体异常。
- 尽管有STICH试验结果,仍有数据支持评估心肌冬眠以预测消除缺血后心室功能改善。
- 交感神经支配成像已验证,但更简单的预后标志物使其未广泛采用;预测植入装置需求的数据不足,但非随机研究有前景。
- 核素成像在心内膜炎、装置感染、结节病心肌炎症、心肌炎及可疑转甲状腺素蛋白淀粉样变沉积检测中 uniquely valuable。
临床怎么用
- 利用心肌灌注显像PET和SPECT评估缺血负荷,辅助分诊药物治疗与血运重建。
- 在心力衰竭患者中可考虑评估心肌冬眠以预测血运重建后功能改善。
- 在疑似心内膜炎、装置感染、结节病、心肌炎或转甲状腺素蛋白淀粉样变时,核素成像可提供独特信息。
局限性
- 部分心脏中心缺乏专业知识。
- 缺乏简单的SPECT量化,可能低估整体异常。
- 交感神经支配成像预测植入装置需求的数据不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Radionuclide imaging remains an essential component of modern cardiology. There is overlap with the information from other imaging techniques, but no technique is static and new developments have expanded its role. This review focuses on ischaemic heart disease, heart failure, infection and inflammation. Radiopharmaceutical development includes the wider availability of positron emission tomography (PET) tracers such as rubidium-82, which allows myocardial perfusion to be quantified in absolute terms. Compared with alternative techniques, myocardial perfusion scintigraphy PET and single photon emission computed tomography (SPECT) have the advantages of being widely applicable using exercise or pharmacological stress, full coverage of the myocardium and a measure of ischaemic burden, which helps to triage patients between medical therapy and revascularisation. Disadvantages include the availability of expertise in some cardiac centres and the lack of simple SPECT quantification, meaning that global abnormalities can be underestimated. In patients with heart failure, despite the findings of the STICH (Surgical Treatment for Ischemic Heart Failure) trial, there are still data to support the assessment of myocardial hibernation in predicting when abolition of ischaemia might lead to improvement in ventricular function. Imaging of sympathetic innervation is well validated, but simpler markers of prognosis mean that it has not been widely adopted. There are insufficient data to support its use in predicting the need for implanted devices, but non-randomised studies are promising. Other areas where radionuclide imaging is uniquely valuable are detection and monitoring of endocarditis, device infection, myocardial inflammation in sarcoidosis, myocarditis and so on, and reliable detection of deposition in suspected transthyretin-related amyloidosis.
引用
- Schofield R, Menezes L, Underwood SR, et al. Nuclear cardiology: state of the art. Heart. 2021. PMID: 33483353. doi:10.1136/heartjnl-2019-315628
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。